Depression Advisor

Major depressive disorder (MDD) is commonly observed in medical settings, with a prevalence of up to 14% compared with 2% to 4% in the general population.1 Various studies have found rates of 12% to 18% in patients with diabetes, 15% to 23% in those with coronary heart disease, 23% to 54% in patients with multiple…

Currently, there is an unmet need for the development of rapid-acting antidepressants aimed at treatment-resistant patients with either major depressive disorder (MDD) or bipolar disorder. A review of existing treatment options, as well as future possibilities, was published in Psychiatry and Clinical Neurosciences.1 Approximately 320 million people worldwide are affected by MDD, with a noted…

Researcher data showed that the boundaries to successful treatment in depression in patients who are minorities are varied, but that there are certain predisposing factors such as adverse childhood events and genetics.